EPS: As of FY2025 Q2, the actual value is USD 0.07.

Segment Revenue

• Interest Income on Marketable Securities Held in Trust Account: $2,477,873 for the three months ended June 30, 2025, and $4,925,132 for the six months ended June 30, 2025.

Operational Metrics

• Net Income: $2,247,708 for the three months ended June 30, 2025, and $4,446,406 for the six months ended June 30, 2025.
• Operating Costs: $230,165 for the three months ended June 30, 2025, and $478,726 for the six months ended June 30, 2025.

Cash Flow

• Net Cash Used in Operating Activities: - $321,655 for the six months ended June 30, 2025.
• Cash and Marketable Securities Held in Trust Account: $241,260,237 as of June 30, 2025.

Unique Metrics

• Deferred Legal Fees: $200,000 as of June 30, 2025.
• Deferred Underwriting Fee Payable: $9,800,000 as of June 30, 2025.

Future Outlook and Strategy

• Core Business Focus: The company intends to use the funds held in the Trust Account primarily to complete a Business Combination. The management has until June 22, 2026, to consummate a Business Combination.
• Non-Core Business: The company may seek to extend the Combination Period consistent with applicable laws, regulations, and stock exchange rules by amending its Amended and Restated Articles. Such an amendment would require the approval of Public Shareholders, who will be provided the opportunity to redeem all or a portion of their Public Shares in connection with the vote on such approval.
• Priority: The company intends to consummate a Business Combination prior to June 22, 2026. No adjustments have been made to the carrying amounts of assets or liabilities should the company be required to liquidate after June 22, 2026.